$0.420
-0.0124 (-2.87%)
At Close: Jul 13, 2026
Vivos Therapeutics Announces Pricing of $21M Initial Public Offering
09:43pm, Thursday, 10'th Dec 2020
HIGHLANDS RANCH, Colo., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“ Vivos ”), a medical technology company that offers novel and proprietary alternatives for treating mild-to-mod
Sign In
Buy VVOS